Goldman Sachs
AGN

Goldman Sachs’s Allergan plc AGN Stock Holding History

Goldman Sachs’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,490,686
Closed -$1.33B – 5658
2020
Q1 		$1.33B Sell
7,490,686
-86,495
-1% -$16.3M 0.47% 24
2019
Q4 		$1.45B Buy
7,577,181
+2,140,951
+39% +$386M 0.37% 36
2019
Q3 		$915M Buy
5,436,230
+3,355,325
+161% +$547M 0.26% 62
2019
Q2 		$348M Buy
2,080,905
+633,861
+44% +$87.8M 0.1% 192
2019
Q1 		$212M Sell
1,447,044
-1,054,733
-42% -$153M 0.06% 341
2018
Q4 		$334M Sell
2,501,777
-557,045
-18% -$91.3M 0.11% 173
2018
Q3 		$583M Buy
3,058,822
+1,153,830
+61% +$212M 0.15% 110
2018
Q2 		$318M Sell
1,904,992
-1,096,049
-37% -$176M 0.09% 218
2018
Q1 		$505M Sell
3,001,041
-352,177
-11% -$59.1M 0.13% 158
2017
Q4 		$549M Buy
3,353,218
+174,416
+5% +$31.3M 0.13% 138
2017
Q3 		$651M Sell
3,178,802
-1,285,575
-29% -$299M 0.16% 99
2017
Q2 		$1.09B Sell
4,464,377
-1,428,502
-24% -$336M 0.28% 40
2017
Q1 		$1.41B Buy
5,892,879
+1,295,834
+28% +$302M 0.38% 30
2016
Q4 		$965M Buy
4,597,045
+1,199,584
+35% +$249M 0.27% 47
2016
Q3 		$782M Buy
3,397,461
+619,688
+22% +$151M 0.24% 53
2016
Q2 		$642M Sell
2,777,773
-863,746
-24% -$199M 0.21% 62
2016
Q1 		$976M Buy
3,641,519
+1,024,829
+39% +$293M 0.32% 34
2015
Q4 		$818M Buy
2,616,690
+140,515
+6% +$41.8M 0.26% 52
2015
Q3 		$673M Buy
2,476,175
+798,418
+48% +$245M 0.23% 63
2015
Q2 		$509M Sell
1,677,757
-408,759
-20% -$122M 0.16% 112
2015
Q1 		$621M Buy
2,086,516
+351,618
+20% +$100M 0.2% 79
2014
Q4 		$447M Buy
1,734,898
+472,383
+37% +$118M 0.14% 131
2014
Q3 		$305M Buy
1,262,515
+183,085
+17% +$41M 0.1% 205
2014
Q2 		$241M Sell
1,079,430
-252,542
-19% -$52.3M 0.08% 286
2014
Q1 		$274M Buy
1,331,972
+259,443
+24% +$51.4M 0.09% 231
2013
Q4 		$180M Sell
1,072,529
-283,011
-21% -$44.2M 0.06% 383
2013
Q3 		$195M Sell
1,355,540
-163,344
-11% -$21.8M 0.07% 303
2013
Q2 		$192M Buy
+1,518,884
New +$172M 0.07% 289

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Goldman Sachs's AGN Position: Q2 2020 in Review

Goldman Sachs sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 7,490,686 shares — an estimated $1.33B sold.

Goldman Sachs first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.45B in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Goldman Sachs reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Goldman Sachs sold 7,490,686 Allergan plc shares in Q2 2020, an estimated $1.33B.
  • Goldman Sachs first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Goldman Sachs's Allergan plc position peaked at $1.45B in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.